Skip to main content
. 2022 Apr 29;13(5):799. doi: 10.3390/genes13050799

Figure 1.

Figure 1

Proportion of gene mutations identified on NGS that would be positive on Idylla molecular testing. (A–C) Percentage of BRAF mutations identified on NGS panel that would be detected on Idylla system and associated Tier classification and primary site diagnosis. (D–F) Percentage of NRAS mutations identified on NGS panel that would be detected on Idylla system and associated Tier classification and primary site diagnosis. (G–I) Percentage of KRAS mutations identified on NGS panel that would be detected on Idylla system and associated Tier classification and primary site diagnosis. (J–L) Percentage of EGFR mutations identified on NGS panel that would be detected on Idylla system and associated Tier classification and primary site diagnosis.